Jason Peterson
Vice President of Investor Relations
Replay available
Sotera Health Company (NASDAQ: SHC) Q4 2025 earnings conference call, held 2026-02-24. Replay captured from the company's public earnings webcast.

Vice President of Investor Relations
Chairman and Chief Executive Officer
Chief Financial Officer
Analyst, BMO Capital Markets
Analyst, Citi
Analyst, KeyBank
Analyst, William Blair
Analyst, JP Morgan
Analyst, Piper Sandler
Analyst, RBC Capital Markets
Analyst, Jefferies
Good morning and welcome to Terra Health fourth quarter and full year 2025 conference call. All participants will be in a listen-only mode. After today's presentation, there will be an opportunity to ask questions. To ask a question, please press star then 1-1 on your touchtone phone. To withdraw your question, please press star 1-1 again. Please note this event is being recorded. I would now like to turn the conference over to Vice President of Investor Relations, Jason Peterson. Jason, please go ahead. Good morning and thank you. Welcome to Soterra Health's fourth quarter and four-year 2025 earnings call. Today's press release and supplemental slides are available on the investor section of our website at soterrahealth.com. This webcast is being recorded and a replay will also be available on the investor section of the Soterra Health website shortly after the call. Joining me today are Chairman and Chief Executive Officer Michael Petras and Chief Financial Officer John Lyons. During the call today, some of our comments may be considered forward-looking statements. The matters addressed in these statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected or implied. Please refer to Sotero Health SEC filings in the forward-looking statement slide at the beginning of the presentation for a description of these risks and uncertainties. The company assumes no obligation to update any such forward-looking statements. Please note that during the discussion today, the company will present both GAAP and non-GAAP financial measures, including adjusted EBITDA, adjusted EBITDA margin, tax rate applicable to net income, adjusted net income, adjusted EPS, adjusted free cash flow, net debt and net leverage ratio, as...